Blog
Posts Categorized: Equities
-
Align Research Recommendations update
As equity markets globally continue to push on in the face of historically extreme valuations whilst seemingly ignoring recession risk in the US and increasing geo-political tensions, we believe that caution is very much warranted now and indeed it is time to actively raise cash and take advantage of the distribution opportunities that the buoyant […]
-
Align Research demonstrates its “eat your own cooking” capability
By Richard Jennings, CFA When we set out to create a new type of research house, one that addressed the issues posed by what is known as Mifid 2 – the separation of research payments from trading commissions – we had in mind an offering to the marketplace that also cut a swathe through the […]
-
Global Resources Investment Trust update – new direction emboldens confidence in 20p price target
By Richard Jennings, CFA We last wrote about GRIT HERE in which we highlighted the massive dislocation in value between the stock price of GRIT and the company’s underlying NAV. At the time, the company was considering a proposal put forward by Primestar that was thankfully kicked into the long grass in the final analysis. The […]
-
Wading into the Valeant Pharmaceuticals investment debate
By Richard Jennings, CFA There have been innumerable articles and countless words written about the implosion of Valeant Pharmaceuticals (VRX) in recent months with the story surrounding the so called “price gouging” (acquiring companies with drug portfolios and jacking up the price to patients by material amounts) and the issue over the company’s circa $30bn […]
-
Selected equity markets now offer compelling value
By Richard Jennings, CFA For investors in global equities the onset of 2016 has most certainly not brought any New Year optimism. Indeed, the incessant Atlantic depressions that have brought misery, wind and rain to many seem rather apt given that many observers point the finger squarely at the embattled Fed for the lacklustre stock […]